Involvement of opioid μ1 receptors in morphine-induced conditioned place preference in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 275-279

  Piepponen, T Petteri ^a   Kivastik, Toomas ^a   Katajamäki, Jaana ^a   Zharkovsky, Alexander ^a   Ahtee, Liisa ^a  

^a Div of Pharmacology and Toxicology   (Finland)

Author keywords

Analgesia; Catalepsy; Conditioned place preference; Hyperthermia; Naloxonazine; Naltrexone; Naltrindole; Opioid receptors

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; NALOXONAZINE; NALTREXONE; NALTRINDOLE; OPIATE ANTAGONIST; RECEPTOR SUBTYPE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; CATALEPSY; CONDITIONING, OPERANT; MALE; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU;

ANIMALIA;

EID: 0030814419     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00567-9     Document Type: Article

References (43)

1. Ahtee L., Kääriäinen I The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus. Eur. J. Pharmacol. 22:1973;206-208.
2. Carroll M. E., Meisch R. A. Concurrent etonitazene and water intake in rats. Role of taste, olfaction, and auditory stimuli Psychopharmacology. 64:1979;1-7.
3. Clark W. G., Clark Y. L. Changes in body temperature after administration of acetylcholine, histamine, morphine, prostaglandins and related agents. Neurosci. Biobehav. Rev. 4:1980;175-240.
4. Corbett A. D., Paterson S. J., Kosterlitz H. W. Selectivity of ligands for opioid receptors. Herz A. Handbook of experimental pharmacology, vol. 104/I. 1993;645-679 Springer-Verlag, Opioids I. Berlin/Heidelberg.
5. Crook T. J., Kitchen I., Hill R. G. Effects of the δ-opioid receptor antagonist naltrindole on antinociceptive responses to selective δ-agonists on post-weanling rats. Br. J. Pharmacol. 107:1992;573-576.
6. Di Chiara G., North R. A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:1992;185-193.
7. Goodman R. R., Adler B. A., Pasternak G. W. Regional distribution of opioid receptors. Pasternak G. W. The opiate receptors. 1988;197-223 The Humana Press, Clifton, NJ.
8. Goodman R. R., Pasternak G. W. Visualization of μ1 opiate receptors in rat brain by using a computerized autoradiographic subtraction technique. Proc. Natl. Acad. Sci. USA. 82:1985;6667-6671.
9. Hahn E. F., Nishimura S., Goodman R. R., Pasternak G. W. Irreversible opiate agonists and antagonists. II. Evidence against bivalent mechanism of action for opiate azines and diacylhydrazones. J. Pharmacol. Exp. Ther. 235:1985;839-850.
10. Herz A., Shippenberg T. S. Neurochemical aspects of addiction. Opioids and other drugs of abuse Goldstein A. Molecular and cellular aspects of the drug addiction. 1989;111-141 Springer-Verlag, New York.
11. Hoffman D. C. The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res. Bull. 23:1989;373-387.
12. Jenck F., Gratton A., Wise R. A. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward. Brain Res. 423:1987;34-38.
13. Kivastik T., Vuorikallas K., Piepponen T. P., Zharkovsky A., Ahtee L. Morphine- and cocaine-induced conditioned place preference. Effects of quinpirole and preclamol Pharmacol. Biochem. Behav. 54:1996;371-375.
14. Kuschinsky K., Hornykiewicz O. Effects of morphine on striatal dopamine metabolism. Possible mechanism of its opposite effect on locomotor activity in rats and mice Eur. J. Pharmacol. 26:1974;41-50.
15. Latimer L. G., Duffy P., Kalivas P. W. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:1986;328-337.
16. Ling G. S. F., Pasternak G. W. Morphine catalepsy in the rat. Involvement of μ1 (high affinity) opioid binding sites Neurosci. Lett. 32:1982;193-196.
17. Ling G. S. F., Simantov R., Clark J. A., Pasternak G. W. Naloxonazine actions in vivo. Eur. J. Pharmacol. 129:1986;33-38.
18. Longoni R., Spina L., Mulas A., Carboni E., Garau L., Melchiorri P., Di Chiara G. D-Ala2) deltorphin II. D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens J. Neurosci. 11:1991;1565-1576.
19. Mann P. E., Arjune D., Romero M. T., Pasternak G. W. Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine. Psychopharmacology. 94:1988;336-341.
20. Mann P. E., Pasternak G. W., Bridges R. S. Mu 1 opioid receptor involvement in maternal behavior. Physiol. Behav. 47:1990;133-138.
21. Mann P. E., Pasternak G. W., Hahn E. F., Curreri G. Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintenance of body weight in rats. Neuropharmacology. 27:1988;349-355.
22. Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
23. Menkens K., Bilsky E. J., Wild K. D., Portoghese P. S., Reid L. D., Porreca F. Cocaine place preference is blocked by the δ-opioid receptor antagonist, naltrindole. Eur. J. Pharmacol. 219:1992;345-346.
24. Meyer M. E., Meyer M. E. Behavioral effects of opioid peptide agonists DAMGO, DPDPE and DAKLI on locomotor activities. Pharmacol. Biochem. Behav. 45:1993;315-320.
25. Moolten M. S., Fishman J. B., Chen J.-C., Carlson K. R. Etonitazene. An opioid selective for the mu receptor types Life Sci. Pharmacol. Lett. 52:1993;PL199-PL203.
26. Negus S. S., Henriksen S. J., Mattox A., Pasternak G. W., Portoghese P. S., Takemori A. E., Weinger M. B., Koob G. F. Effect of antagonists selective for mu, δ and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265:1993;1245-1252.
27. 1 receptor-mediated effect. J. Pharmacol. Exp. Ther. 252:1990;235-240.
28. Pasternak G. W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
29. Pasternak G. W., Wood P. J. Minireview. Multiple mu opiate receptors Life Sci. 38:1986;1889-1898.
30. Saito H. Inhibitory and stimulatory effects of morphine on locomotor activity in mice. Biochemical and behavioral studies Pharmacol. Biochem. Behav. 35:1989;231-235.
31. Sala M., Braida D., Calcaterra P., Leone M. P., Gori E. Dose-dependent conditioned place preference produced by etonitazene and morphine. Eur. J. Pharmacol. 217:1992;37-41.
32. Shippenberg T. S. Motivational effects of opioids. Herz A. Handbook of experimental pharmacology, vol. 104/II. 1993;633-649 Springer-Verlag, Opioids II. Berlin/Heidelberg.
33. Shippenberg T. S., Bals-Kubik R., Herz A. Motivational properties of opioids. Evidence that an activation of δ-receptors mediates reinforcement processes Brain Res. 436:1987;234-239.
34. Simone D. A., Bodnar R. J., Goldman E. J., Pasternak G. W. Involvement of opioid receptor subtypes in rat feeding behavior. Life Sci. 36:1984;829-833.
35. Simone D. A., Bodnar R. J., Portzline T., Pasternak G. W. Antagonism of morphine analgesia by intracerebroventricular naloxonazine. Pharmacol. Biochem. Behav. 24:1986;1721-1727.
36. Suzuki T., Funada M., Narita M., Misawa M., Nagase H. Pertussis toxin abolishes μ- and δ-opioid agonist-induced place preference. Eur. J. Pharmacol. 205:1991;85-88.
37. Suzuki T., Funada M., Narita M., Misawa M., Nagase H. Morphine-induced place preference in the CXBK mouse. Characteristics of μ opioid subtypes Brain Res. 602:1993;45-52.
38. Suzuki T., George F. R., Meisch R. A. Etonitazene delivered orally serves as a reinforcer for Lewis but not Fischer 344 rats. Pharmacol. Biochem. Behav. 42:1992;579-586.
39. Suzuki T., Yoshiike M., Mizoguchi H., Kamei J., Misawa M., Nagase H. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice. Jpn. J. Pharmacol. 66:1994;131-137.
40. Traynor J. R., Elliott J. δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol. Sci. 14:1993;84-86.
41. Waksman G., Hamel E., Fournie Zaluski M. C., Roques B. P. Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and δ opioid receptors in rat brain. Proc. Natl. Acad. Sci. USA. 83:1986;1523-1527.
42. Wolozin B. L., Pasternak G. W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA. 78:1981;6181-6185.
43. Woolfe G., MacDonald A. D. The evaluation of analgesic action of pethidine hydrochloride (demerol). J. Pharmacol. Exp. Ther. 80:1944;300-307.